Zobrazeno 1 - 10
of 6 004
pro vyhledávání: '"adefovir"'
Autor:
Abdelbary, Ghada A.1 gabdelbary@gmail.com, Amin, Maha M.1, Zakaria, Mohamed Y.2, El Awdan, Sally A.3
Publikováno v:
Journal of Liposome Research. Dec2018, Vol. 28 Issue 4, p259-274. 16p.
Autor:
Seo, Jeong-Woong1, Hwang, Kyu-Min1, Lee, Sung-Hoon2, Kim, Dong-Wook2 pharmengin@cju.ac.kr, Park, Eun-Seok1 espark@skku.edu
Publikováno v:
Pharmaceutical Development & Technology. Nov2018, Vol. 23 Issue 9, p890-899. 10p.
Autor:
Ho PARK
Publikováno v:
Korean Journal of Clinical Laboratory Science, Vol 55, Iss 4, Pp 284-290 (2023)
Adefovir dipivoxil (ADV) is used for the treatment of hepatitis and acquired immunodeficiency syndrome, but long-term use can cause osteoporosis. In this study, the effect of ADV on the osteocyte maturation process was evaluated at the level of undif
Externí odkaz:
https://doaj.org/article/da8d204de30b4afbbf6b45b9d48e8f7f
Autor:
武晓丽1
Publikováno v:
Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. Dec2017, Vol. 33 Issue 12, p2311-2315. 5p.
Publikováno v:
Experimental & Therapeutic Medicine. Dec2017, Vol. 14 Issue 6, p5837-5842. 6p.
Publikováno v:
Asian Journal of Surgery, Vol 46, Iss 12, Pp 5468-5470 (2023)
Externí odkaz:
https://doaj.org/article/b045c51dadb84722b88fde631ee61c28
Publikováno v:
Iranian Journal of Pharmaceutical Research. Winter2017, Vol. 16 Issue 1, p132-139. 8p.
Autor:
YONG LIN1, FAN PAN2, YINGCHAO WANG3, ZIQIAN CHEN4 chenziqian_fuzong@163.com, CHUN LIN1, LVFENG YAO1, XIN ZHANG1, RUI ZHOU1, CHEN PAN1 panchencry@163.com
Publikováno v:
Oncology Letters. Jan2017, Vol. 13 Issue 1, p307-314. 8p.
Autor:
Jian-Hong Zhong1, Yang Ke1,2, Shao-Liang Zhu1, Lin Wang2, Cheng-Piao Luo3, Wen-Feng Gong1, Xue-Mei You1, Liang Ma1, Bang-De Xiang1 xiangbangde@gmail.com, Le-Qun Li1 xitongpingjia@163.com
Publikováno v:
OncoTargets & Therapy. Nov2016, Vol. 9, p6897-6907. 11p.